Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox. Here’s what CNBC TV’s producers were watching on Thursday and what’s on the radar for Friday’s session. The markets From the high to the low, the Dow lost 660 points today. The Dow is now down 0.57% since the inauguration, but up 2.4% since the November election. From the high to the low, the S & P 500 lost 135 points today. The broad-based index is down 2.25% since the inauguration. It is up 1.36% since the November election. From the high to the low, the Nasdaq lost 707 points today. The Nasdaq is down 5.53% since the inauguration. It is up 0.57% since the November election. The Nasdaq 100 lost 783 points today from the high to the low. The Nasdadq 100 is down 4.15% since the inauguration. It is up 1.6% since the November election. The Russell It is down 5.36% since the November election. The Russell is down 6% since the inauguration. LSEG, which helps us keep stats and facts, says 1,122 companies in the Russell 2000 have reported earnings so far this quarter, with 62.7% beating expectations and 30.3% missing expectations. Companies are reporting earnings that are about 6.8% above expectations this quarter. Our neighbors to the North and South The iShares MSCI Canada ETF (EWC) , which tracks Canada, fell 1.52% Thursday. It is 5.84% from the December high. The iShares MSCI Mexico ETF (EWW) , which covers the Mexican market, fell 1.75% Thursday. It is down 28% from the April high. CNBC TV’s Megan Cassella will report on what’s next on the tariff issue tomorrow. Universal Health Services UHS 1Y mountain Universal Health Services shares over the past year. CEO Marc Miller is on Worldwide Exchange , starting bright and early at 5 a.m. ET on Friday. The stock was up 3.3% on Thursday, but it is 23.5% from its September high. The company reported this morning, beating estimates, helped by increased hospital admissions. The S & P Health Care Sector is up 6.76% so far this year, making it the top sector. CVS Health is the leading stock, up 43.6% in 2025. Solventum is second, with a 26% gain, and Gilead Sciences is up 21%, in third. West Pharmaceutical Services , Moderna and Viatris are at the bottom of the pile, all down 23% or more so far this year.
